{"id":1016206,"date":"2026-11-02T12:53:17","date_gmt":"2026-11-02T17:53:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/"},"modified":"2026-11-02T12:53:17","modified_gmt":"2026-11-02T17:53:17","slug":"compass-therapeutics-to-participate-in-upcoming-november-investor-events-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/","title":{"rendered":"Compass Therapeutics to Participate in Upcoming November Investor Events"},"content":{"rendered":"
\n

BOSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of November\/this quarter.<\/p>\n

\n Details are as follows:<\/strong>\n <\/p>\n

\n Guggenheim 3rd Annual Healthcare Innovation Conference<\/strong>
\n
Date: Monday, November 9, 2026
Time: 1:30 PM ET
Webcast Link: https:\/\/event.summitcast.com\/view\/<\/a><\/p>\n

\n Stifel 2026 Healthcare Conference<\/strong>
\n
Date: Wednesday, November 11, 2026
Time: 11:20 AM ET
Webcast Link: https:\/\/event.summitcast.com\/view\/<\/a><\/p>\n

\n Virtual\/Replay availability:\u00a0<\/strong>Presentations will be archived on Compass\u2019\u00a0Events<\/strong><\/a>\u00a0page.<\/p>\n

Compass\u2019 management will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings.<\/p>\n

\n About Compass Therapeutics<\/strong>
\n
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company dedicated to transforming the standard of care for patients with cancer through the discovery and development of innovative antibody-based therapeutics. The company leverages deep expertise in tumor biology and proprietary antibody engineering technologies to develop differentiated therapies that target the intersection of angiogenesis, immune activation, and tumor-driven immunosuppression. Compass has a robust pipeline of novel product candidates designed to address significant unmet needs and improve outcomes for patients with cancer. The Company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at\u00a0https:\/\/www.compasstherapeutics.com<\/strong><\/a><\/p>\n

\n Investor Contact<\/strong>
\n
\n
\n ir@compasstherapeutics.com<\/strong>
\n <\/a>\n <\/p>\n

\n Media Contact<\/strong>
\n
Anna Gifford, Chief of Staff
media@compasstherapeutics.com<\/strong><\/a>
617-500-8099<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

BOSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of November\/this quarter. Details are as follows: Guggenheim 3rd Annual Healthcare Innovation Conference Date: Monday, November 9, 2026 Time: 1:30 PM ETWebcast Link: https:\/\/event.summitcast.com\/view\/ Stifel 2026 Healthcare Conference Date: Wednesday, November 11, 2026Time: 11:20 AM ETWebcast Link: https:\/\/event.summitcast.com\/view\/ Virtual\/Replay availability:\u00a0Presentations will be archived on Compass\u2019\u00a0Events\u00a0page. Compass\u2019 management will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings. About Compass Therapeutics Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company dedicated to … <\/p>\n

Continue reading “Compass Therapeutics to Participate in Upcoming November Investor Events”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1016206","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCompass Therapeutics to Participate in Upcoming November Investor Events - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Compass Therapeutics to Participate in Upcoming November Investor Events - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of November\/this quarter. Details are as follows: Guggenheim 3rd Annual Healthcare Innovation Conference Date: Monday, November 9, 2026 Time: 1:30 PM ETWebcast Link: https:\/\/event.summitcast.com\/view\/ Stifel 2026 Healthcare Conference Date: Wednesday, November 11, 2026Time: 11:20 AM ETWebcast Link: https:\/\/event.summitcast.com\/view\/ Virtual\/Replay availability:\u00a0Presentations will be archived on Compass\u2019\u00a0Events\u00a0page. Compass\u2019 management will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings. About Compass Therapeutics Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company dedicated to … Continue reading "Compass Therapeutics to Participate in Upcoming November Investor Events"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-02T17:53:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2Nzk1OCM3OTM5NTY5IzIyMDI0MjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Compass Therapeutics to Participate in Upcoming November Investor Events\",\"datePublished\":\"2026-11-02T17:53:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\\\/\"},\"wordCount\":243,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2Nzk1OCM3OTM5NTY5IzIyMDI0MjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\\\/\",\"name\":\"Compass Therapeutics to Participate in Upcoming November Investor Events - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2Nzk1OCM3OTM5NTY5IzIyMDI0MjI=\",\"datePublished\":\"2026-11-02T17:53:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2Nzk1OCM3OTM5NTY5IzIyMDI0MjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2Nzk1OCM3OTM5NTY5IzIyMDI0MjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Compass Therapeutics to Participate in Upcoming November Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Compass Therapeutics to Participate in Upcoming November Investor Events - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/","og_locale":"en_US","og_type":"article","og_title":"Compass Therapeutics to Participate in Upcoming November Investor Events - Market Newsdesk","og_description":"BOSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of November\/this quarter. Details are as follows: Guggenheim 3rd Annual Healthcare Innovation Conference Date: Monday, November 9, 2026 Time: 1:30 PM ETWebcast Link: https:\/\/event.summitcast.com\/view\/ Stifel 2026 Healthcare Conference Date: Wednesday, November 11, 2026Time: 11:20 AM ETWebcast Link: https:\/\/event.summitcast.com\/view\/ Virtual\/Replay availability:\u00a0Presentations will be archived on Compass\u2019\u00a0Events\u00a0page. Compass\u2019 management will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings. About Compass Therapeutics Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company dedicated to … Continue reading \"Compass Therapeutics to Participate in Upcoming November Investor Events\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-02T17:53:17+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2Nzk1OCM3OTM5NTY5IzIyMDI0MjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Compass Therapeutics to Participate in Upcoming November Investor Events","datePublished":"2026-11-02T17:53:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/"},"wordCount":243,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2Nzk1OCM3OTM5NTY5IzIyMDI0MjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/","name":"Compass Therapeutics to Participate in Upcoming November Investor Events - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2Nzk1OCM3OTM5NTY5IzIyMDI0MjI=","datePublished":"2026-11-02T17:53:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2Nzk1OCM3OTM5NTY5IzIyMDI0MjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2Nzk1OCM3OTM5NTY5IzIyMDI0MjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-upcoming-november-investor-events-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Compass Therapeutics to Participate in Upcoming November Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016206","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1016206"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016206\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1016206"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1016206"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1016206"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}